FDA Recall Terminated

Boston Scientific, Implantable Cardioverter Defibrillator, DYNAGEN EL ICD DR, Model D152 - Product Usage: Implantable cardioverter defibrillators (ICDs) are intended to provide ventricular anti-tachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

Recall: Z-1512-2020 · Initiated February 12, 2020

Recall

Recall Number
Z-1512-2020
Event Number
85077
Firm
Boston Scientific Corporation
FEI Number
2124215
Product Code
LWS
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
February 12, 2020
Posted
March 3, 2020
Terminated
April 14, 2023
Address
4100 Hamline Ave N, Bldg 3, Saint Paul, MN, 55112-5700

Description

Boston Scientific, Implantable Cardioverter Defibrillator, DYNAGEN EL ICD DR, Model D152 - Product Usage: Implantable cardioverter defibrillators (ICDs) are intended to provide ventricular anti-tachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

Reason

Boston Scientific released a new Software Update Application that was downloaded to four (4) distributed Model 3300 programmers. The Software Update Application then directed these programmers to download software applications that have not been approved by the US Food and Drug Administration.

Action

The firm initiated the recall by letter on 12/12/2020. The letter explained the error and requested the consignee segregate the units for removal. The firm will provide another model of programmer to be used in the interim.

Distribution

US Nationwide distribution in the states of NC, TN, and MO.

Quantity

1 device